These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 10587522

  • 1. Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein.
    Ohh M, Takagi Y, Aso T, Stebbins CE, Pavletich NP, Zbar B, Conaway RC, Conaway JW, Kaelin WG.
    J Clin Invest; 1999 Dec; 104(11):1583-91. PubMed ID: 10587522
    [Abstract] [Full Text] [Related]

  • 2. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
    Clifford SC, Astuti D, Hooper L, Maxwell PH, Ratcliffe PJ, Maher ER.
    Oncogene; 2001 Aug 16; 20(36):5067-74. PubMed ID: 11526493
    [Abstract] [Full Text] [Related]

  • 3. Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity.
    Hansen WJ, Ohh M, Moslehi J, Kondo K, Kaelin WG, Welch WJ.
    Mol Cell Biol; 2002 Mar 16; 22(6):1947-60. PubMed ID: 11865071
    [Abstract] [Full Text] [Related]

  • 4. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.
    Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG.
    Science; 1995 Sep 08; 269(5229):1444-6. PubMed ID: 7660130
    [Abstract] [Full Text] [Related]

  • 5. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.
    Lonergan KM, Iliopoulos O, Ohh M, Kamura T, Conaway RC, Conaway JW, Kaelin WG.
    Mol Cell Biol; 1998 Feb 08; 18(2):732-41. PubMed ID: 9447969
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The von Hippel-Lindau tumour suppressor protein: new perspectives.
    Ohh M, Kaelin WG.
    Mol Med Today; 1999 Jun 08; 5(6):257-63. PubMed ID: 10366821
    [Abstract] [Full Text] [Related]

  • 9. Identification of elongin C sequences required for interaction with the von Hippel-Lindau tumor suppressor protein.
    Takagi Y, Pause A, Conaway RC, Conaway JW.
    J Biol Chem; 1997 Oct 24; 272(43):27444-9. PubMed ID: 9341197
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Solution structure and dynamics of yeast elongin C in complex with a von Hippel-Lindau peptide.
    Botuyan MV, Mer G, Yi GS, Koth CM, Case DA, Edwards AM, Chazin WJ, Arrowsmith CH.
    J Mol Biol; 2001 Sep 07; 312(1):177-86. PubMed ID: 11545595
    [Abstract] [Full Text] [Related]

  • 13. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.
    Pause A, Lee S, Worrell RA, Chen DY, Burgess WH, Linehan WM, Klausner RD.
    Proc Natl Acad Sci U S A; 1997 Mar 18; 94(6):2156-61. PubMed ID: 9122164
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Formation of the VHL-elongin BC tumor suppressor complex is mediated by the chaperonin TRiC.
    Feldman DE, Thulasiraman V, Ferreyra RG, Frydman J.
    Mol Cell; 1999 Dec 18; 4(6):1051-61. PubMed ID: 10635329
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Binding of elongin A or a von Hippel-Lindau peptide stabilizes the structure of yeast elongin C.
    Botuyan MV, Koth CM, Mer G, Chakrabartty A, Conaway JW, Conaway RC, Edwards AM, Arrowsmith CH, Chazin WJ.
    Proc Natl Acad Sci U S A; 1999 Aug 03; 96(16):9033-8. PubMed ID: 10430890
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of transcription elongation by the VHL tumor suppressor protein.
    Duan DR, Pause A, Burgess WH, Aso T, Chen DY, Garrett KP, Conaway RC, Conaway JW, Linehan WM, Klausner RD.
    Science; 1995 Sep 08; 269(5229):1402-6. PubMed ID: 7660122
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.